Literature DB >> 29270633

Evaluation of Industry Relationships Among Authors of Otolaryngology Clinical Practice Guidelines.

Jarryd Horn1, Jake Xavier Checketts1, Omar Jawhar2, Matt Vassar3.   

Abstract

IMPORTANCE: Financial relationships between physicians and industry have influence on patient care. Therefore, organizations producing clinical practice guidelines (CPGs) must have policies limiting financial conflicts during guideline development.
OBJECTIVES: To evaluate payments received by physician authors of otolaryngology CPGs, compare disclosure statements for accuracy, and investigate the extent to which the American Academy of Otolaryngology-Head and Neck Surgery complied with standards for guideline development from the Institute of Medicine (IOM). DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional analysis retrieved CPGs from the American Academy of Otolaryngology-Head and Neck Surgery Foundation that were published or revised from January 1, 2013, through December 31, 2015, by 49 authors. Data were retrieved from December 1 through 31, 2016. Industry payments received by authors were extracted using the Centers for Medicare & Medicaid Services Open Payments database. The values and types of these payments were then evaluated and used to determine whether self-reported disclosure statements were accurate and whether guidelines adhered to applicable IOM standards. MAIN OUTCOMES AND MEASURES: The monetary amounts and types of payments received by physicians who author otolaryngology guidelines and the accuracy of disclosure statements.
RESULTS: Of the 49 physicians in this sample, 39 (80%) received an industry payment. Twenty-one authors (43%) accepted more than $1000; 12 (24%), more than $10 000; 7 (14%), more than $50 000; and 2 (4%), more than $100 000. Mean (SD) financial payments amounted to $18 431 ($53 459) per physician. Total reimbursement for all authors was $995 282. Disclosure statements disagreed with the Open Payments database for 3 authors, amounting to approximately $20 000 among them. Of the 3 IOM standards assessed, only 1 was consistently enforced. CONCLUSIONS AND RELEVANCE: Some CPG authors failed to fully disclose all financial conflicts of interest, and most guideline development panels and chairpersons had conflicts. In addition, adherence to IOM standards for guideline development was lacking. This study is relevant to CPG panels authoring recommendations, physicians implementing CPGs to guide patient care, and the organizations establishing policies for guideline development.

Entities:  

Mesh:

Year:  2018        PMID: 29270633      PMCID: PMC5885864          DOI: 10.1001/jamaoto.2017.2741

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  29 in total

Review 1.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

2.  Conflict of Interest Disclosure Policies and Practices in Peer-reviewed Biomedical Journals.

Authors:  Richelle J Cooper; Malkeet Gupta; Michael S Wilkes; Jerome R Hoffman
Journal:  J Gen Intern Med       Date:  2006-12       Impact factor: 5.128

Review 3.  Conflict of interest reporting in otolaryngology clinical practice guidelines.

Authors:  Gordon H Sun
Journal:  Otolaryngol Head Neck Surg       Date:  2013-05-23       Impact factor: 3.497

4.  Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary.

Authors:  M M Chren; C S Landefeld
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

5.  How to decide whether a clinical practice guideline is trustworthy.

Authors:  David F Ransohoff; Michael Pignone; Harold C Sox
Journal:  JAMA       Date:  2013-01-09       Impact factor: 56.272

6.  Clinical Practice Guideline Development Manual, Third Edition: a quality-driven approach for translating evidence into action.

Authors:  Richard M Rosenfeld; Richard N Shiffman; Peter Robertson
Journal:  Otolaryngol Head Neck Surg       Date:  2013-01       Impact factor: 3.497

7.  Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.

Authors:  Colette DeJong; Thomas Aguilar; Chien-Wen Tseng; Grace A Lin; W John Boscardin; R Adams Dudley
Journal:  JAMA Intern Med       Date:  2016-08-01       Impact factor: 21.873

8.  Conflict of Interest in Seminal Hepatitis C Virus and Cholesterol Management Guidelines.

Authors:  Akilah A Jefferson; Steven D Pearson
Journal:  JAMA Intern Med       Date:  2017-03-01       Impact factor: 21.873

Review 9.  Conflict of interest in clinical practice guideline development: a systematic review.

Authors:  Susan L Norris; Haley K Holmer; Lauren A Ogden; Brittany U Burda
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

10.  Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors.

Authors:  Aaron P Mitchell; Ethan M Basch; Stacie B Dusetzina
Journal:  JAMA Oncol       Date:  2016-12-01       Impact factor: 31.777

View more
  9 in total

1.  Financial Conflicts of Interest of United States-Based Authors in Neurology Journals: Cross-Sectional Study Using the Open Payments Database.

Authors:  Jade E Smith; Charlotte Wahle; James L Bernat; Nathaniel M Robbins
Journal:  Neurology       Date:  2021-02-25       Impact factor: 9.910

2.  A cross-sectional examination of conflict-of-interest disclosures of physician-authors publishing in high-impact US medical journals.

Authors:  James H Baraldi; Steven A Picozzo; Jacob C Arnold; Kathryn Volarich; Michael R Gionfriddo; Brian J Piper
Journal:  BMJ Open       Date:  2022-04-11       Impact factor: 3.006

3.  Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.

Authors:  Camilla Hansen Nejstgaard; Lisa Bero; Asbjørn Hróbjartsson; Anders W Jørgensen; Karsten Juhl Jørgensen; Mary Le; Andreas Lundh
Journal:  Cochrane Database Syst Rev       Date:  2020-12-08

4.  Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories.

Authors:  Ray Moynihan; Alexandra Lai; Huw Jarvis; Geraint Duggan; Stephanie Goodrick; Elaine Beller; Lisa Bero
Journal:  BMJ Open       Date:  2019-02-05       Impact factor: 2.692

5.  Analysis of payments to GI physicians in the United States: Open payments data study.

Authors:  Venu Gopala Reddy Gangireddy; Rajan Amin; Kevin Yu; Praveen Kanneganti; Swathi Talla; Amarnath Annapureddy
Journal:  JGH Open       Date:  2020-08-21

6.  A meta-epidemiological assessment of transparency indicators of infectious disease models.

Authors:  Emmanuel A Zavalis; John P A Ioannidis
Journal:  PLoS One       Date:  2022-10-07       Impact factor: 3.752

Review 7.  Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels.

Authors:  Salman Nusrat; Taseen Syed; Sanober Nusrat; Sixia Chen; Wei-Jen Chen; Klaus Bielefeldt
Journal:  JAMA Netw Open       Date:  2018-12-07

8.  Drivers of the opioid crisis: An appraisal of financial conflicts of interest in clinical practice guideline panels at the peak of opioid prescribing.

Authors:  Sheryl Spithoff; Pamela Leece; Frank Sullivan; Nav Persaud; Peter Belesiotis; Liane Steiner
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

9.  Sunshine on KOLs: assessment of the nature, extent and evolution of financial ties between the leaders of professional medical associations and the pharmaceutical industry in France from 2014 to 2019: a retrospective study.

Authors:  Marie Clinckemaillie; Alexandre Scanff; Florian Naudet; Adriaan Barbaroux
Journal:  BMJ Open       Date:  2022-02-02       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.